Chemokines and their role in tumor growth and metastasis

Journal of Immunological Methods

Volumn 220, Issue 1-2, 1998, Pages 1-17

  Wang, Ji Ming ^a   Deng, Xiyun ^a   Gong, Wanghua ^b   Su, Shaobo ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Chemokines; Growth and metastasis of tumors; Leukocyte

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

CELL PROLIFERATION; GENETIC TRANSDUCTION; HUMAN; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNOLOGY;

EID: 0001825042     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00128-8     Document Type: Article

References (101)

1. Akira S., Kishimoto T. NF-IL6 and NF-kB in cytokine gene regulation. Adv. Immunol. 65:1997;1-33.
2. Amara A., Gall S.L., Schwartz O., Salamero J., Montes M., Loetscher P., Baggiolini M., Virelizier J.L., Arenzana-Seisdedos F. HIV co-receptor downregulation as antiviral principle: SDF1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:1997;139-146.
3. Angiolillo A.L., Sgadari C., Taub D.D., Liao F., Farber J.M., Maheshwari S., Kleinman H.K., Reaman G.H., Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:1995;155-162.
4. Arenberg D.A., Polverini P.J., Kunkel S.L., Shanafelt A., Hesselgesser J., Horuk R., Strieter R.M. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J. Leukoc. Biol. 62:1997;554-562.
5. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 385:1997;347-349.
6. Asher A.L., Mule J.J., Kasid A., Restifo N.P., Salo J.C., Reichert C.M., Jaffe G., Fendly B., Kriegler M., Rosenberg S.A. Murine tumor cells transduced with the gene for tumor necrosis factor-alpha: evidence for paracrine immune effects of tumor necrosis factor against tumors. J. Immunol. 146:1991;3227-3234.
7. Baggiolini M., Deward B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:1994;97-178.
8. Baggiolini M., Deward B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 5:1997;675-705.
9. Balentien E., Mufson B.E., Shattuck R.L., Derynck R., Richmond A. Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene. 6:1991;1115-1124.
10. 3C motif. Nature. 385:1997;640-644.
11. Ben-Baruch A., Michiel D.F., Oppenheim J.J. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270:1995;11703-11706.
12. Benke R., Schirrmacher V. Change in organotropism of mouse lymphoma variants associated with selective chemotactic responsiveness to organ-derived chemoattractants. Clin. Exp. Metastasis. 9:1991;205-219.
13. Bordoni R., Fine R., Murray D., Richmond A. Characterization of the role of melanoma growth stimulating activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J. Cell. Biochem. 44:1990;207-219.
14. Bottazzi B., Polentarutti N., Acero R., Balsari A., Boraschi D., Ghezzi P., Salmona M., Mantovani A. Regulation of the macrophage content of neoplasms by chemoattractants. Science. 220:1983;210-212.
15. Bottazzi B., Luini W., Govoni D., Colotta F., Mantovani A. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148(1):1992;280-1285.
16. Chitnis C.E., Chaudhuri A., Horuk R., Pogo A.O., Miller L.H. The domain on the Duffy blood group antigen for binding plasmodium vivax and P. knowlesi malaria parasites to erythrocytes. J. Exp. Med. 184:1996;1531-1536.
17. + T cells. Science. 70:1995;1811-1815.
18. Cook D.N., Beck M.A., Coffman T.M., Kirby S.L., Sheridan J.F., Pragnell I.B., Smithies O. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science. 269:1995;1583-1585.
19. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 273:1996;1856-1862.
20. Dilloo D., Bacon K., Holden W., Zhong W., Burdach S., Zlotnik A., Brenner M. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nature Med. 2:1996;1090-1095.
21. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levisky H., Brose K., Jackson V., Hamada H., Pardoll D., Mulligan R.C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factors stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:1993;3539-3543.
22. Gao J.L., Wynn T.A., Chang Y., Lee E.J., Broxmeyer H.E., Cooper S., Tiffany H.L., Westphal H., Kwon-Chung J., Murphy P.M. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1997;1959-1968.
23. Gerard C., Frossard J.L., Bhatia M., Saluja A., Gerard N.P., Lu B., Steer M. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:1997;2022-2027.
24. Gong W., Howard O.M.Z., Turpin J.A., Grimm M.C., Ueda H., Gray P.W., Raport C.J., Oppenheim J.J., Wang J.M. Monocyte chemotactic protein (MCP)-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 fusion/replication. J. Biol. Chem. 273:1998;4289-4292.
25. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 391:1998;799-803.
26. Guo H.G., Browning P., Nicholas J., Hayward G.S., Tschachler E., Jiang Y.W., Sadowska M., Raffeld M., Colombini S., Gallo R.C., Reitz M.S. Jr. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology. 228:1997;371-378.
27. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukocyte Biol. 56:1994;559-564.
28. Hirose K., Hakozaki M., Nyunoya Y., Kobayashi Y., Matsushita K., Takenouchi T., Mikata A., Mukaida N., Matsushima K. Chemokine gene transfection into tumor cells reduced tumorigenicity in nude mice in association with neutrophil infiltration. Br. J. Cancer. 72:1995;708-714.
29. Horuk R., Yansura D.G., Reilly D., Spencer S., Bourell J., Henzel W., Rice G., Unemori E. Purification, receptor binding analysis, and biologic characterization of human melanoma growth-stimulating activity: evidence for a novel receptor. J. Biol. Chem. 268:1993;541-546.
30. Horuk R., Martin A., Hesselgesser J., Hadley T., Lu Z.H., Wang Z.X., Peiper S.C. The Duffy antigen receptor for chemokine: structural analysis and expression in the brain. J. Leukocyte Biol. 59:1996;29-38.
31. Horuk R., Hesselgesser J., Zhou Y., Faulds D., Halks-Miller M., Harvey S., Taub D., Samson M., Parmentier M., Rucker J., Doranz B.J., Doms R.W. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem. 273:1998;386-391.
32. Hoshino Y., Hatake K., Kasahara T., Takahashi Y., Ikeda M., Tomizuka H., Ohtsuki T., Uwai M., Mukaida N., Matsushima K., Miura Y. Monocyte chemoattractant protein-1 stimulates tumor necrosis and recruitment of macrophages into tumors in tumor-bearing nude mice: increased granulocyte and macrophage progenitors in murine bone marrow. Exp. Hematol. 23:1995;1035-1039.
33. Huang S., Singh R.K., Xie K., Gutman M., Berry K.K., Bucana C.D.I., Fidler J., Bar-Eli M. Expression of the JE/MCP-1 gene suppress metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother. 39:1994;231-238.
34. 3CR1, which mediates both leukocyte migration and adhesion. Cell. 91:1997;521-530.
35. Kelner G.S., Kennedy J., Bacon K.B., Kleyensteuber S., Largaespada D.A., Jenkins N.A., Copeland N.G., Bazan J.F., Moore K.W., Schall T.J., Zlonik A. Lymphotactin: a cytokine that represents a new class of chemokine. Science. 266:1994;1395-1399.
36. Kolber D.L., Knisely T.L., Maione T.E. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J. Natl. Cancer Inst. 87:1995;304-309.
37. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1997;1757-1762.
38. Laning J., Kawasaki H., Tanaka E., Luo Y., Dorf M.E. Inhibition of in vivo tumor growth by the β chemokine, TCA3. J. Immunol. 153:1994;4625-4635.
39. Legler D.F., Loetscher M., Roos R.S., Clark-Lewis I., Baggiolini M., Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187:1998;655-660.
40. Liao F., Alkhatib G., Peden K.W., Sharma G., Berger E.A., Farber J.M. SRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185:1997;2015-2023.
41. Luan J., Shattuck-Brandt R., Haghnegahdar H., Owen J.D., Strieter R., Burdick M., Nirodi C., Beauchamp D., Johnson K.N., Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukocyte Biol. 62:1997;588-597.
42. Luca M., Huang S., Gershenwald J.E., Singh R.K., Reich R., Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol. 151:1997;1105-1113.
43. Luster A.D., Leder P. IP-10, a -C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178:1993;1057-1065.
44. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., Carson H.F., Sharpe R.J. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 247:1990;77-79.
45. Manome Y., Wen P.Y., Hershowitz A., Tanaka T., Rollins B.J., Kufe D.W., Fine H.A. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41:1995;227-235.
46. Mantovani A. Biology of disease, tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest. 71:1994;5-16.
47. Mantovani A., Locati M., Allavena P., Sozzani S. The chemokine superfamily: crosstalk with the IL-1 system. Immunobiology. 195:1996;522-549.
48. Mazzucchelli L., Loetscher P., Kappeler A., Uguccioni M., Baggiolini M., Laissue J.A., Mueller C. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am. J. Pathol. 149:1996;501-509.
49. Monteclaro F.S., Arai H., Charo I.F. Molecular approaches to identifying ligand binding and signaling domains of C-C chemokine receptors. Methods Enzymol. 288:1997;70-84.
50. Moore J.P., Trkola A. HIV type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res. Hum. Retroviruses. 13:1997;733-736.
51. Moser B., Barella L.S., Mattei S., Schumacher C., Boulay F., Colombo M.P., Baggiolini M. Expression of transcripts for two interleukin-8 receptors in human phagocytes, lymphocytes, and melanoma cells. Biochem. J. 294:1993;285-292.
52. Mueller S.G., Schraw W.P., Richmond A. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in nonhemopoietic cells. J. Biol. Chem. 269:1994;1973-1980.
53. Mueller S.G., Schraw W.P., Richmond A. Activation of protein kinase C enhances the phosphorylation of the type Binterleukin-8 receptor and stimulates its degradation in non-hematopoietic cells. J. Biol. Chem. 270:1995;10439-10448.
54. Mueller S.G., White J.R., Schraw W.P., Lam V., Richmond A. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J. Biol. Chem. 272:1997;8207-8214.
55. Mulé J.J., Custer M., Averbook B., Yang J.C., Weber J.S., Goeddel D.V., Rosenberg S.A., Schall T.J. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Human Gene Therapy. 7:1996;1545-1553.
56. Murphy P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:1996;47-64.
57. Murphy P., Alexander P., Senior P.V., Fleming J., Kirkham N., Taylor I. Mechanisms of organ selective tumor growth by bloodborne cancer cells. Br. J. Cancer. 57:1988;19-31.
58. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:1996;635-638.
59. Nakashima E., Mukaida N., Kubota Y., Kuno K., Yasumoto K., Ichimura F., Nakanishi I., Miyasaka M., Matsushima K. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vitro. Pharmaceutical Res. 12:1995;1598-1604.
60. Nakashima E., Oya A., Kubota Y., Kanada N., Matsushita R., Takeda K., Ichimura F., Kuno K., Mukaida N., Hirose K., Nakanishi I., Ujiie T., Matsushima K. A candidate for cancer gene therapy: MIP-1α gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice. Pharmaceutical Res. 13:1996;1896-1901.
61. Negus R.P.M., Stamp G.W.H., Hadley J., Balkwill F.R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150:1997;1723-1734.
62. Negus R.P.M., Stamp G.W.H., Relf M.G., Burke F., Malik S.T.A., Bernasconi S., Allavena P., Sozzani S., Mantovani A., Balkwill F.R. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95:1995;2391-2396.
63. Nicolson G.L. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer and Metastasis Rev. 12:1993;325-343.
64. Norgauer J., Metzner B., Schraufstatter I. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J. Immunol. 156:1996;1132-1137.
65. Noris M., Bernasconi S., Casiraghi F., Sozzani S., Gotti E., Remuzzi G., Matovani A. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with Lupus nephritis. Lab. Invest. 73:1995;804-809.
66. Opdenakker G., Van Damme J. Cytokines and proteases in invasive process: molecular similarities between inflammation and cancer. Cytokine. 4:1992;251-258.
67. Oppenheim, J.J., Wang, J.M., Chertov, O., Taub, D.D., Ben-Baruch, A., 1996. The role of chemokines in transplantation biology. In: Tilney, N.L., Strom, T.B., Paul, L.C. (Eds.), Cellular and Molecular Aspects. Lippincott-Raven, Philadelphia, pp. 182-200.
68. Owen J.D., Strieter R., Burdick M., Haghnegahdar H., Nanney L., Shattuck-Brandt R., Richmond A. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins. Int. J. Cancer. 73:1997;94-103.
69. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J.A., Vath J., Gosselin M., Ma J., Dussault B., Woolf E., Alperin G., Culpepper J., Gutierrez-Ramos J.C., Gearing D. Neurotactin, a novel membrane-anchored chemokine that is upregulated in brain inflammation. Nature. 387:1997;611-617.
70. Paxton W.A., Martin S.R., Tse D., O'Brien T.R., Skurnick J., VanDevanter N.L., Padian N., Braun J.F., Kotler D.P., Wolinsky S.M., Koup R.A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Med. 2:1996;412-417.
71. Pleskoff O., Treboute C., Brelot A., Heveker N., Seman M., Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Nature. 276:1997;1874-1878.
72. Premack B.A., Schall T.J. Chemokine receptors: gateways to inflammation and infection. Nature Med. 2:1996;1174-1178.
73. Richards B.L., Eisma R.J., Spiro J.D., Lindquist R.L., Kreutzer D.L. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am. J. Surg. 174:1997;507-512.
74. Richmond A., Thomas H.G. Purification of melanoma growth stimulatory activity. J. Cell. Physiol. 129:1986;375-384.
75. Rollins B.J., Sunday M.E. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11:1991;3125-3131.
76. Rothenberg M.E., MacLean J.A., Pearlman E., Luster A.D., Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:1997;785-790.
77. Schadendorf D., Moller A., Algermissen B., Worm M., Sticherling M., Czarnetzki B.M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151:1993;2267-2275.
78. Sgadari C., Angiolillo A.L., Cherney B.W., Pike S.E., Farber J.M., Koniaris L.G., Vanguri P., Burd P.R., Sheikh N., Gupta G., Teruya-Feldstein J., Tosato G. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;13791-13796.
79. Sgadari C., Farber J.M., Angiolillo A.L., Liao F., Teruya-Feldstein J., Burd P.R., Yao L., Gupta G., Kanegane C., Tosato G. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood. 89:1997;2635-2643.
80. Sharpe R.J., Byers H.R., Scott C.F., Bauer S.I., Maione T.E. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J. Natl. Cancer Inst. 82:1990;848-853.
81. Smith D.R., Polverini P.J., Kunkel S.L., Orringer M.B., Whyte R.I., Burdick M.D., Wilke C.A., Strieter R.M. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med. 179:1994;1409-1415.
82. Sozzani S., Locati M., Zhou D., Rieppi M., Luini W., Lamorte G., Bianchi G., Polentarutti N., Allavena P., Mantovani A. Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines. J. Leukocyte Biol. 57:1995;788-794.
83. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriott D., Chan S.Y., Roczniak S., Shanafelt A.B. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:1995;27348-27357.
84. Strieter R.M., Polverini P.J., Arenberg D.A., Walz A., Opdenakker G., Van Damme J., Kunkel S.L. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukocyte Biol. 57:1995;752-762.
85. Svennevig J.L., Svaar H. Content and distribution of macrophages and lymphocytes in solid malignant human tumors. Int. J. Cancer. 24:1979;754-758.
86. Tahara H., Zeh H. III, Storkus W., Pappo I., Watkins S.C., Gubler U., Wolf S.F., Robbins P.D., Lotze M.T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54:1994;182-189.
87. Tang W.W., Yin S., Wittwer A.J., Qi M. Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am. J. Physiol. 269:1995;F323-F330. (3 Pt 2).
88. Taub D.D., Oppenheim J.J. Chemokines, inflammation and the immune system. Ther. Immunol. 1:1994;229-246.
89. Van Damme J., Proost P., Lenaerts J.P., Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:1992;59-65.
90. Verschueren H., Van Der Taelen I., Dewit J., De Braekeleer J., De Baetselier P. Metastatic competence of BW5147 T lymphoma cell lines is correlated with in vitro metastasis. J. Leukocyte Biol. 55:1994;552-556.
91. Wakabayashi H., Cavanaugh P.G., Nicolson G.L. Purification and identification of mouse microvessel endothelial cell-derived chemoattractant for lung-metastasizing murine RAW117 large-cell lymphoma cells: identification as mouse monocyte chemotactic protein. Cancer Res. 55:1995;4458-4464.
92. Wang J.M., Taraboretti G., Matsushima K., Van Damme J., Mantovani A. IL-8 induces haptotaxis and chemotaxis of melanoma cells. Biochem. Biophys. Res. Commun. 169:1990;165-169.
93. Wang J.M., Chertov O., Proost P., Li J.-J., Menten P., Xu L., Sozzani S., Mantovani A., Gong W., Schirrmacher V., Van Damme J., Oppenheim J.J. Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFκB activation. Int. J. Cancer. 75:1998;900-907.
94. Wenzel U.O., Abboud H.E. Chemokines and renal disease. Am. J. Kidney Dis. 26:1995;982-994.
95. Witt D.P., Lander A.D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:1994;392-400.
96. Wong L.M., Myers S.J., Tsou C.L., Gosling J., Arai H., Charo I.F. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J. Biol. Chem. 272:1997;1038-1045.
97. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J., Leonard E.J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1989;1449-1459.
98. Young S.J., Ali S.A., Taub D.D., Rees R.C. Chemokines induce migrational responses in human breast carcinoma cells. Int. J. Cancer. 71:1997;257-266.
99. Zachariae C.O., Anderson A.O., Thompson H.L., Appella E., Mantovani A., Oppenhiem J.J., Matsushima K. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 171:1990;2177-2182.
100. Zhou Y., Kurihara T., Ryseck R.P., Yang Y., Ryan C., Loy J., Warr G., Bravo R. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160:1998;4018-4025.
101. Zoja C., Wang J.M., Bettoni S., Sironi M., Renzi D., Chiaffarino F., Abboud H.E., Mantovani A., Remuzzi G., Rambaldi A. Interleukin-1β and tumor necrosis factor-α induce gene expression and production of leukocyte chemotactic factors, colony stimulating factors and interleukin-6 in human mesangial cells. Am. J. Pathol. 138:1991;991-1003.